Relationship between the metabolic syndrome and the incidence of stroke after complete coronary revascularization over a 10-year follow-up period

Atherosclerosis

Volumn 207, Issue 1, 2009, Pages 195-199

  Kasai, Takatoshi ^a   Miyauchi, Katsumi ^a   Kajimoto, Kan ^a   Kubota, Naozumi ^a   Yanagisawa, Naotake ^a   Amano, Atsushi ^a   Daida, Hiroyuki ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Coronary artery bypass graft; Long term; Mortality; Percutaneous coronary intervention

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ARTICLE; BODY MASS; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY RECANALIZATION; DISEASE ASSOCIATION; DISEASE COURSE; FATALITY; FEMALE; HIGH RISK PATIENT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PREDICTION; PRIORITY JOURNAL;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; KAPLAN-MEIERS ESTIMATE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; STROKE; TIME FACTORS; TREATMENT OUTCOME;

EID: 70350564332     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.04.028     Document Type: Article

References (25)

1. Wilson P.W., D'Agostino R.B., Parise H., Sullivan L., and Meigs J.B. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 112 (2005) 3066-3072
2. McNeill A.M., Rosamond W.D., Girman C.J., et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 28 (2005) 385-390
3. Eberly L.E., Prineas R., Cohen J.D., et al. Metabolic syndrome: risk factor distribution and 18-year mortality in the multiple risk factor intervention trial. Diabetes Care 29 (2006) 123-130
4. Sundstrom J., Riserus U., Byberg L., et al. Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: prospective, population based cohort study. Br Med J 332 (2006) 878-882
5. Najarian R.M., Sullivan L.M., Kannel W.R., et al. Metabolic syndrome compared with type 2 diabetes mellitus as a risk factor for stroke. The Framingham Offspring Study. Arch Intern Med 166 (2006) 106-111
6. Kurl S., Laukkanen J.A., Niskanen L., et al. Metabolic syndrome and the risk of stroke in middle-aged men. Stroke 37 (2006) 806-811
7. Iso H., Sato S., Kitamura A., Imano H., et al. Metabolic syndrome and the risk of ischemic heart disease and stroke among Japanese men and women. Stroke 38 (2007) 1744-1751
8. Nigam A., Bourassa M.G., Fortier A., Guertin M.C., and Tardif J.C. The metabolic syndrome and its components and the long term risk of death in patients with coronary heart disease. Am Heart J 151 (2006) 514-521
9. Kasai T., Miyauchi K., Kurata T., et al. Prognostic value of the metabolic syndrome for long-term outcomes in patients undergoing percutaneous coronary intervention. Circ J 70 (2006) 1531-1537
10. Jones E.L., and Weintraub W.S. The importance of completeness of revascularization during long-term follow-up after coronary artery operations. J Thorac Cardiovasc Surg 112 (1996) 227-237
11. McLellan C.S., Ghali W.A., Labinaz M., et al. Alberta Provincial Project for Outcomes Assessment in Coronary Heart Disease (APPROACH) Investigators. Association between completeness of percutaneous coronary revascularization and postprocedure outcomes. Am Heart J 150 (2005) 800-806
12. Grundy S.M., Cleeman J.I., Daniels S.R., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart Lung and Blood Institute scientific statement. Circulation 112 (2005) 2735-2752
13. Examination Committee of Criteria for 'Obesity Disease' in Japan. Japan Society for the Study of Obesity: new criteria for 'obesity disease' in Japan. Circ J 2002;66:987-92.
14. Ko G.T., Cockram C.S., Chow C.C., et al. High prevalence of metabolic syndrome in Hong Kong Chinese comparison of three diagnostic criteria. Diabetes Res Clin Pract 69 (2005) 160-168
15. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 30 Suppl. 1 (2007) S42-47
16. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., and Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130 (1999) 461-470
17. World Health Organization. WHO STEPS stroke manual: the WHO STEPwise approach to stroke surveillance (2006), World Health Organization, Geneva
18. Yusuf S., Hawken S., Ounpuu S., et al. Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control study. Lancet 366 (2005) 1640-1649
19. Gil-Nunez A. The metabolic syndrome and cerebrovascular disease: suspicion and evidence. Cerebrovasc Dis 24 Suppl. 1 (2007) 64-75
20. He Y., Jiang B., Wang J., et al. Prevalence of the metabolic syndrome and its relation to cardiovascular disease in an elderly Chinese population. J Am Coll Cardiol 47 (2006) 1588-1594
21. Kawamoto R., Tomita H., Oka Y., and Kodama A. Metabolic syndrome as a predictor of ischemic stroke in elderly persons. Intern Med 44 (2005) 922-927
22. Milionis H.J., Rizos E., Goudevenos J., et al. Components of the metabolic syndrome and risk for first-ever acute ischemic nonembolic stroke in elderly subjects. Stroke 36 (2005) 1372-1376
23. Koren-Morag N., Goldbourt U., and Tanne D. Relation between the metabolic syndrome and ischemic stroke or transient ischemic attack A prospective cohort study in patients with atherosclerotic cardiovascular disease. Stroke 36 (2005) 1366-1371
24. Wong N.D., Sciammarella M.G., Polk D., et al. The metabolic syndrome, diabetes, and subclinical atherosclerosis assessed by coronary calcium. J Am Coll Cardiol 41 (2003) 1547-1553
25. Janssen I., Katzmarzyk P.T., and Ross R. Body mass index, waist circumference, and health risk. Arch Intern Med 162 (2002) 2074-2079